Deutsche Bank AG Has $15.14 Million Stock Holdings in Maximus, Inc. (NYSE:MMS)

Deutsche Bank AG lifted its stake in Maximus, Inc. (NYSE:MMS) by 8.3% during the fourth quarter, HoldingsChannel reports. The fund owned 202,834 shares of the health services provider’s stock after purchasing an additional 15,539 shares during the quarter. Deutsche Bank AG’s holdings in Maximus were worth $15,142,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. UMB Bank n.a. raised its holdings in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after buying an additional 158 shares in the last quarter. Eastern Bank bought a new position in Maximus during the fourth quarter valued at about $29,000. V Square Quantitative Management LLC raised its holdings in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after buying an additional 180 shares in the last quarter. R Squared Ltd bought a new position in Maximus during the fourth quarter valued at about $54,000. Finally, IFP Advisors Inc raised its holdings in Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after buying an additional 302 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Price Performance

NYSE MMS opened at $75.34 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The stock’s 50-day moving average is $68.58 and its two-hundred day moving average is $72.84. The firm has a market cap of $4.26 billion, a P/E ratio of 16.20 and a beta of 0.61. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period in the previous year, the company posted $1.57 earnings per share. The firm’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.59%. Maximus’s payout ratio is presently 23.86%.

Insider Transactions at Maximus

In related news, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jan Madsen sold 2,439 shares of the business’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares of the company’s stock, valued at $1,225,347.87. This trade represents a 11.88% decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

Separately, StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a report on Thursday.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.